Search
for
Sort by
Research 151–180 of 398
- Clinical Assessment of Alopecia Areata Severity and Validating the Patient Experience: A Vodcast
- Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- Patient Validation of Estimation of Health Utility Values in Alopecia Areata
- Epidermal stem cells and skin tissue engineering in hair follicle regeneration
- Autoimmunity and autoimmune co-morbidities in psoriasis
- Development of a DNA-analytical Method for the Identification of Animal Hair Fibers in Textiles
- A guide to studying human dermal adipocytes in situ
- NFIC promotes the vitality and osteogenic differentiation of rat dental follicle cells
- Finasteride-Induced Inhibition of 5α-Reductase Type 2 Could Lead to Kidney Damage—Animal, Experimental Study
- Identification of the key proteins associated with different hair types in sheep and goats
- Construction strategies of skin organoids: A review
- Scalp hair cortisol concentration in patients with alopecia areata and correlate its level with the disease variables
- Patched-assoziierte Tumoren: Modifikatorgene und Pathogenese
- Endocrinologia e Medicina Estética Ed. X
- Psychosocial Aspects of Skin Conditions and Diseases
- Successful treatment of Notoedres cati-infested kitten using selamectin spot-on: A case report
- A brief review on nutrition management and lifestyle modification in hypothyroidism
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study
- 67 Patterns of clinical response in patients with alopecia areata (AA) treated with ritlecitinib in the ALLEGRO phase 2b/3 and ongoing, phase 3, ALLEGRO-LT studies
- 186 Mechanistic insights into Ritlecitinib-mediated immunomodulation in Alopecia Areata
- Systematic review and indirect treatment comparisons of ritlecitinib against baricitinib in alopecia areata
- Using patient preference to inform ritlecitinib dose selection for alopecia areata treatment
- A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata
- A Patient Preference-Weighted Quantitative Benefit-Risk Analysis of Ritlecitinib for Alopecia Areata to Inform Medical Decision Making
- Safety and Efficacy of Ritlecitinib for the Treatment of Patients with Alopecia Areata: A Systematic Review and Meta-Analysis of Controlled Trials
- A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata
- Etrasimod for alopecia areata: The scenario for a less extensive and moderate form
- Loss of ERBB2 and ERBB3 Receptors Impacts Epidermal Differentiation in Mice
- Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme
- Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial